MPM BioVentures 2014, L.P., 10% Owner at Entrada Therapeutics, Inc. (TRDA), sold 86,914 shares at $7.20 ($616K) on 2026-08-27, disclosed to the SEC on 2026-08-31.
Open-market sale of $616k TRDA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.20 | 38,922 | $280K | 45.5% |
| 2 | $7.01 | 3,733 | $26K | 4.2% |
| 3 | $6.99 | 44,259 | $309K | 50.2% |
| Total | $7.08 avg | 86,914 | $616K | 100% |
| Filing → |
| TRDA | SELL | 2026-08-26 | $462K | — | Filing → |
| HOWL | SELL | 2025-11-12 | $438K | — | Filing → |
| ITOS | SELL | 2021-10-18 | $939K | — | Filing → |